Researcher Database

Harada Hiroshi

■Faculty	Hematology
■Position	Visiting Professor

Last Updated :2025/04/01

【臨床血液内科学-病態解明と診断・治療の新展開-】骨髄不全症, 原田　浩史, 昭和学士会雑誌, 82(3):148 - 165, Jul. 2022, Peer-reviewed, DOI:https://doi.org/10.14930/jshowaunivsoc.82.148

予防投与量のST合剤でSIADHによる低Na血症が疑われた1例, 米澤　龍;藤宮　龍祥;伊藤　真理;田中　広紀;原田　浩史;渡邊　徹, 日本病院薬剤師学会雑誌, 56(11):1329 - 1334, Nov. 2020, Peer-reviewed

Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome., HATTORI Norimichi;SAITO Bungo;SASAKI Yohei;SHIMADA Shotaro;MURAI So;ABE Maasa;BABA Yuta;WATANUKI Megumi;FUJIWARA Shun;KAWAGUCHI Yukiko;ARAI Nana;KABASAWA Nobuyuki;TSUKAMOTO Hiroyuki;UTO Yui;ARIIZUMI Hirotsugu;YANAGISAWA Kouji;HARADA Hiroshi;NAKAMAKI Tsuyoshi, Biol Blood Marrow Transplant, 24(9):1841 - 1847, Sep. 2018, Peer-reviewed

Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome., BABA Yuta;SAITO Bungo;SHIMADA Shotaro;SASAKI Yohei;MURAI So;ABE Maasa;FUJIWARA Shun;ARAI Nana;KAWAGUCHI Yukiko;KABASAWA Nobuyuki;TSUKAMOTO Hiroyuki;UTO Yui;ARIIZUMI Hirotsugu;YANAGISAWA Kouji;HATTORI Norimichi;HARADA Hiroshi;NAKAMAKI Tsuyoshi, Leuk Res, 67:56 - 59, Apr. 2018, Peer-reviewed

Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma., KAWAGUCHI Yukiko;NAKAMAKI Tsuyoshi;ABE Maasa;BABA Yuta;MURAI So;WATANUKI Megumi;ARAI Nana;FUJIWARA Shun;KABASAWA Nobuyuki;TSUKAMOTO Hiroyuki;UTO Yui;ARIIZUMI Hirotsugu;YANAGISAWA Kouji;HATTORI Norimichi;HARADA Hiroshi;SAITO Bungo, Acta Haematol, 139(1):12 - 18, Feb. 2018, Peer-reviewed

Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin's lymphoma patients undergoing repeated cycles of the CHOP regimen., SAITO Bungo;NAKASHIMA Hidetoshi;ABE Maasa;MURAI So;BABA Yuta;ARAI Nana;KAWAGUCHI Yukiko;FUJIWARA Shun;KABASAWA Nobuyuki;TSUKAMOTO Hiroyuki;UTO Yui;ARIIZUMI Hirotsugu;YANAGISAWA Kouji;HATTORI Norimichi;HARADA Hiroshi;NAKAMAKI Tsuyoshi, Support Care Cancer, 26(1):269 - 274, Jan. 2018, Peer-reviewed

Post-cytokine-release salt wasting as inverse tumor lysis syndrome in a non-cerebral natural killer-cell neoplasm, ARIIZUMI Hirotsugu;SASAKI Yosuke;HARADA Hiroshi;UTO Yui;AZUMA Remi;ISOBE Tomohide;KISHIMOTO Koji;SHIOZAWA Eisuke;TAKIMOTO Masafumi;OHIKE Nobuyuki;MORI Hiraku, Intern Med, 56(14):1855 - 1861, Jul. 2017, Peer-reviewed

Age and Bone Marrow Cellularity are Associated with Response to Eltrombopag in Japanese Adult Immune Thrombocytopenia Patients: A Retrospective Single-Center Study., UTO Yui;FUJIWARA Shun;ARAI Nana;KAWAGUCHI Yukiko;KABASAWA Nobuyuki;TSUKAMOTO Hiroyuki;ARIIZUMI Hirotsugu;HATTORI Norimichi;SAITO Bungo;YANAGISAWA Kouji;HARADA Hiroshi;MORI Hiraku;SHIOZAWA Eisuke;NAKAMAKI Tsuyoshi, 臨床病理, 63(5):548 - 556, May 2015, Peer-reviewed

Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma, ARIIZUMI Hirotsugu;SAITO Bungo;UTO Yui;HATTORI Norimichi;NAKASHIMA Hidetoshi;YANAGISAWA Kouji;HARADA Hiroshi;MORI Hiraku;NAKAMAKI Tsuyoshi, Bone Marrow Transplant, 50(2):301 - 303, Feb. 2015, Peer-reviewed

ホジキンリンパ腫に対するABVD療法により高トリグリセリド血症を生じた一例, 米澤　龍;島本　一志;蒲澤　宣幸;佐野　瑞希;田中　志津子;松井　美月;原田　浩史;須永　登美子, 日本病院薬剤師会関東ブロック第51回学術大会, 28 Aug. 2021, Web開催

予防投与量のST合剤でSIADHによる低Na血症が疑われた1例, 米澤　龍;藤宮　龍祥;伊藤　真理;永尾　美智瑠;秋山（田中）　菜央;松井　美月;戸村　和希;島本　一志;田中　広紀;原田　浩史;渡邊　徹, 日本病院薬剤師会関東ブロック第50回学術大会, 31 Oct. 2020, Web開催

頭皮原発ランゲルハンス細胞肉腫に対しIMRT(強度変調放射線治療)にて治療を行った一例, 岡部　尚行;新城　秀典;橋本　東児;加賀美　芳和;原田　浩史;大池　信之, 平成29年度神奈川県放射線医会総会及び第58回例会, 07 Oct. 2017, 横浜

Single-dose palonosetron for prevention of CHOP induced nausea and vomiting: a phase II study, SAITO Bungo;NAKASHIMA Hidetoshi;ABE Maasa;WATANUKI Megumi;BABA Yuta;MURAI So;FUJIWARA Shun;ARAI Nana;KAWAGUCHI Yukiko;KABASAWA Nobuyuki;TSUKAMOTO Hiroyuki;UTO Yui;ARIIZUMI Hirotsugu;YANAGISAWA Kouji;HATTORI Norimichi;HARADA Hiroshi;MORI Hiraku;NAKAMAKI Tsuyoshi, 第78回日本血液学会学術集会, 13 Oct. 2016, 横浜